VAXZEVRIA
VAXZEVRIA
Authorization By Interim Order Revoked
DIN Number
02511444
Drug Class
Human
Market Date
N/A
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02511444
AIG Number0162722001
Classification & Schedule
C
Drug Class
Human
S
Schedule
COVID-19 - IO - Authorization
,
Schedule D
A
ATC Code
J07BN02 COVID-19, VIRAL VECTOR, NON-REPLICATING
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CHADOX1-S [RECOMBINANT]Active
Strength: 50000000000 VP / 0.5 ML
Monograph: CHADOX1-S [RECOMBINANT]